...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - Jan 7, 2016 - Details
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Whatever the start date, Don (from Masila's notes) said... "We are hoping to see results by the summer."

Realistically, I'll be looking for results in the fall.

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply